Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 584.52% and ...

Novartis says it's not interested in joining weight-loss drugs frenzy. CEO Vas Narasimhan explained why today on CNBC's "Squawk Box Europe".

With a new investment in its two manufacturing sites in Ireland, Eli Lilly continues implementing the largest expansion ...

In July 2024, Sanders co-wrote an opinion piece with President Joe Biden—published in USA Today—taking aim at both Novo and ...

Jim Cramer warned that if the housing market rally keeps going, it might lead to a sell-off if the Federal Reserve announces ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

The demand for medications like Ozempic continues to cause shortages for both those seeking weight loss and patients with ...

Eli Lilly and Company’s LLY stock has risen 21.1% in six months compared with an increase of 10.5% for the industry. The ...

The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...

Consistent in their evaluation, an analyst from JP Morgan keeps a Overweight rating on Eli Lilly with a target price of $1100 ...

Most trillion-dollar companies today are in the technology sector, but one particular healthcare stock is knocking on the ...

In metabolic dysfunction-associated steatotic liver disease, a retrospective analysis shows that patients on GLP-1 receptor ...